Skip to main content
TipRanks
Go Ultimate75% OFF

Amneal Pharmaceuticals (2DT) Income Statement

2 Followers

Amneal Pharmaceuticals Income Statement

Last quarter (Q3 2026), Amneal Pharmaceuticals's total revenue was $862.68M, an increase of 9.96% from the same quarter last year. In Q3, Amneal Pharmaceuticals's net income was $-7.46M. See Amneal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 3.02B$ 2.79B$ 2.39B$ 2.21B$ 2.09B
$ 1.14B$ 1.02B$ 863.87M$ 791.46M$ 768.97M
$ 713.00M$ 771.11M$ 659.50M$ 886.39M$ 616.26M
Depreciation and Amortization$ 223.57M$ 236.19M$ 229.40M$ 240.18M$ 233.41M
$ 603.87M$ 439.77M$ 500.78M$ 440.21M$ 401.10M
$ 423.09M$ 249.33M$ 204.37M$ -94.93M$ 152.72M
$ -283.88M$ -304.34M$ -244.64M$ -153.20M$ -121.35M
$ 139.21M$ -55.01M$ -40.27M$ -248.13M$ 31.37M
$ 72.06M$ -116.89M$ -83.99M$ -129.99M$ 10.62M
Per Share Metrics
Basic EPS$ 0.23$ -0.38$ -0.48$ -0.86$ 0.07
Diluted EPS$ 0.22$ -0.38$ -0.48$ -0.86$ 0.07
Weighted Average Shares Outstanding313.37M308.98M174.99M150.94M148.92M
Weighted Average Shares Outstanding (Diluted)324.81M308.98M176.14M150.94M151.82M

Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

-2B02B4B-40 %-20 %0 %20 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin